Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
54.91
+0.62 (+1.15%)
Streaming Delayed Price
Updated: 11:47 AM EST, Jan 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,285,262
Open
54.53
Bid (Size)
54.90 (500)
Ask (Size)
54.91 (400)
Prev. Close
54.28
Today's Range
54.33 - 55.00
52wk Range
42.52 - 63.33
Shares Outstanding
2,222,113,553
Dividend Yield
4.52%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Top Dividend Stocks Yielding More Than 4% to Buy Hand Over Fist This Year
↗
Today 7:20 EST
All three can provide you with solid, consistent income.
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
World Trade
3 Unpopular Stocks That Concern Us
January 28, 2026
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...
Via
StockStory
Performance
YTD
+2.7%
+2.7%
1 Month
+1.3%
+1.3%
3 Month
+20.4%
+20.4%
6 Month
+26.8%
+26.8%
1 Year
-7.0%
-7.0%
More News
Read More
Bristol-Myers Squibb Co (NYSE:BMY) Shows Strong Technical Setup for Potential Breakout
↗
January 28, 2026
Via
Chartmill
The Post-Keytruda Pivot: Inside Merck’s Strategic Evolution and the RVMD Landscape
January 26, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Intellectual Property
Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Stock With a Path to Growth
↗
January 17, 2026
Via
Chartmill
The $6 Billion Disconnect: Why Revolution Medicines (RVMD) Plunged 20% After Merck Talks Collapsed
January 26, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
2 Under-the-Radar Biotech Stocks Set to Boom in 2026
↗
January 24, 2026
Via
The Motley Fool
Topics
ETFs
Intellectual Property
World Trade
AI Bubble or Sustainable Growth? Here Are 2 Healthcare Companies Harnessing AI for the Long Term.
↗
January 23, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?
↗
January 23, 2026
Via
The Motley Fool
Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth
January 22, 2026
Via
MarketMinute
Topics
Earnings
Economy
Intellectual Property
The Best Stocks to Invest $1,000 in Right Now
↗
January 21, 2026
Via
The Motley Fool
Topics
Intellectual Property
Bristol Myers Squibb Announces Collaboration with Microsoft to Advance AI-Driven Early Detection of Lung Cancer
January 20, 2026
From
Bristol Myers Squibb
Via
Business Wire
2 Dividend Stocks to Buy and Hold For 10 Years
↗
January 19, 2026
Via
The Motley Fool
Topics
Intellectual Property
2 Buffett Stocks to Load Up On—And 1 to Ditch
↗
January 19, 2026
Via
MarketBeat
The Execution Engine: How Merck is Dominating the 2026 Pharma Landscape
January 15, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Thursday's session: gap up and gap down stock in the S&P500 index
↗
January 15, 2026
Via
Chartmill
3 Value Stocks That Fall Short
January 14, 2026
Via
StockStory
3 S&P 500 Stocks Walking a Fine Line
January 13, 2026
Via
StockStory
Topics
Stocks
The Great Recalibration: Why 2026 Could Be Healthcare’s Year to Rebound
January 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
The AI-Bio Convergence: Lilly and Nvidia Kick Off JPM26 with Landmark $1 Billion Alliance
January 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
January 12, 2026
From
Bristol Myers Squibb
Via
Business Wire
Eli Lilly Solidifies Immunology Dominance with $1.2 Billion Acquisition of Ventyx Biosciences
January 09, 2026
Via
MarketMinute
J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs
↗
January 08, 2026
Via
Stocktwits
Topics
Government
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
January 08, 2026
Via
MarketMinute
Topics
Intellectual Property
The 2026 Pharma M&A Outlook: Obesity, HIV, and the Biotech Renaissance
January 07, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Frequently Asked Questions
Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 54.91
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 01/30/26 11:47 AM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 122.01B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 122B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.